drug

nirsevimab

1 story · latest Oct 15, 2026

Follow nirsevimab. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jul 2023 · BLA761328
Brand: Beyfortus

Relationships

Developed by AstraZeneca

Timeline

Sanofi registers new RSV immunization survey; three prior Queensland studies also update

Oct 15Weekly roundup, 7 itemsSanofiUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.